These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3279496

  • 41. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
    Groeneveld AJ, Brouwers JR.
    Pharm Weekbl Sci; 1986 Feb 21; 8(1):79-84. PubMed ID: 2938073
    [Abstract] [Full Text] [Related]

  • 42. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S72-5. PubMed ID: 3481439
    [Abstract] [Full Text] [Related]

  • 43. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Dec 11; 11(4):253-7. PubMed ID: 2941257
    [Abstract] [Full Text] [Related]

  • 44. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Monk JP, Campoli-Richards DM.
    Drugs; 1987 Apr 11; 33(4):346-91. PubMed ID: 3297617
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The role of 4-quinolones in the treatment of infections.
    Cynamon MH, Wilcox GH.
    Compr Ther; 1987 Feb 11; 13(2):37-43. PubMed ID: 3545658
    [No Abstract] [Full Text] [Related]

  • 48. [Gyrase inhibitors: unwanted central nervous system effects].
    Rietbrock N, Staib AH.
    Dtsch Med Wochenschr; 1987 Jan 30; 112(5):201. PubMed ID: 3467948
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P, Dopp C.
    Internist (Berl); 1989 Jan 30; 30(1):20-31. PubMed ID: 2646237
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P, Mazzei T, Nicoletti P.
    Chemioterapia; 1987 Apr 30; 6(2):75-8. PubMed ID: 3474081
    [Abstract] [Full Text] [Related]

  • 54. Use of animal models in evaluation of the quinolones.
    Sande MA, Brooks-Fournier RA, Gerberding JL.
    Rev Infect Dis; 1988 Apr 30; 10 Suppl 1():S113-6. PubMed ID: 3279487
    [Abstract] [Full Text] [Related]

  • 55. Quinolones in the treatment of lower respiratory tract infections.
    Thys JP, Jacobs F, Motte S.
    Rev Infect Dis; 1989 Apr 30; 11 Suppl 5():S1212-9. PubMed ID: 2672250
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
    Dubreuil L, Devos J, Romond C, Bryskier A.
    Pathol Biol (Paris); 1985 May 30; 33(5):421-5. PubMed ID: 3162143
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT.
    Scand J Infect Dis Suppl; 1986 May 30; 49():115-23. PubMed ID: 3547618
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.